vTv Therapeutics Inc. (VTVT) News
Follow vTv Therapeutics Inc. (VTVT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
vTv Therapeutics Reports Quarterly Results for Period Ended September 30
The company reported results for the quarter ended September 30.
EQUITY | Nov 05, 2026, 10:29 PM UTC
M
vTv Therapeutics Reports Q3 Net Loss of $11.6 Million; CATT1 Enrollment Complete
vTv Therapeutics reported a third-quarter 2026 net loss attributable to shareholders of $11.6 million, or $0.94 per share, versus a loss of $8.7 million, or $1.08 per share, a year earlier. It had $77.2 million in cash a
EQUITY | Nov 05, 2026, 09:47 PM UTC
L
vTv Therapeutics 3Q Loss/Shr 94c >VTVT
vTv Therapeutics 3Q Loss/Shr 94c >VTVT
EQUITY | Nov 05, 2026, 09:01 PM UTC
L
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 15, 2026, 08:05 PM UTC
L
VTVT management to participate in September investor conferences
VTVT announced management will participate in September investor conferences. The company is advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D).
EQUITY | Sep 02, 2026, 12:07 PM UTC
L
VTVT - vTv Therapeutics to Participate in September Investor Conferences
VTVT - vTv Therapeutics to Participate in September Investor Conferences
EQUITY | Sep 02, 2026, 12:01 PM UTC
L
vTv Therapeutics announces Nasdaq Rule 5635(c)(4) inducement grants
vTv Therapeutics (VTVT) announces inducement grants under Nasdaq Listing Rule 5635(c)(4), with details provided by the company in its release; no grant size or terms were included in the feed.
REGULATION | Aug 19, 2026, 08:06 PM UTC
L
VTVT - vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
VTVT - vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 06, 2026, 12:00 PM UTC
L
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
EQUITY | Jul 28, 2026, 08:06 PM UTC